A review of the Quarterly which is remarkable for one very interesting comment - re the Valuation!
$10.00!
"Valuation is raised to $10.00 from $4.00. We acknowledge this is a step change, however, the major driver is the current market capitalisation $A1.985 bn (US$1.3 bn) relative to transaction values for what we believe are inferior assets (refer figure 3). The assets continue in clinical stage development by CU6 continue to show outstanding safety with good indications of efficacy supported by composition of matter patients. The revised DCF model supported by recent M&A in the radiopharmaceuticals space..."
Thank you Bell Potter!
My view - Clarity Pharmaceuticals remains cheap.
CU6 - Media and Industry News, page-343
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.10 |
Change
0.040(0.57%) |
Mkt cap ! $2.251B | |||
| Open | High | Low | Value | Volume |
| $7.17 | $7.17 | $6.82 | $3.910M | 558.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 20814 | $7.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.74 | 19914 | 4 |
View Market Depth
| Last trade - 15.59pm 14/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |